About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Mayo Clinic
›
Division of Hematology
›
Top Articles
Division of Hematology
Mayo Clinic
8.1K
Articles
237.5K
Citations
3.1
avg. Impact Factor
199
h-index
Most Cited Articles of Division of Hematology in 2004
Title
Journal
Year
Citations
Multiple myeloma
New England Journal of Medicine
2004
1.2K
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis
Journal of Clinical Oncology
2004
593
Genetics and cytogenetics of multiple myeloma: a workshop report
Cancer Research
2004
560
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer
Journal of Clinical Oncology
2004
544
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Blood
2004
266
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
Blood
2004
248
Clinical cardiac tolerability of trastuzumab
Journal of Clinical Oncology
2004
224
Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
Blood
2004
195
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
Blood
2004
193
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome
Blood
2004
193
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia
Blood
2004
177
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature
Blood
2004
174
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98)
Leukemia and Lymphoma
2004
161
Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study
Cancer
2004
154
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
Blood
2004
148
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades
Cancer
2004
145
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
Blood
2004
123
Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome
Journal of Biological Chemistry
2004
122
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma
Blood
2004
110
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial
Journal of Clinical Oncology
2004
108
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate
Bone Marrow Transplantation
2004
90
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma
Leukemia
2004
88
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma
Bone Marrow Transplantation
2004
80
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
Leukemia
2004
79
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma
Leukemia
2004
79
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.